Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin

Cohen, Arlan; Moschopoulos, Panagis; Stiehm, Richard E.; Koren, Gideon
February 2011
CMAJ: Canadian Medical Association Journal;2/8/2011, Vol. 183 Issue 2, p204
Academic Journal
The article focuses on the secondary prevention of congenital varicella syndrome using varicella-zoster immune globulin. It mentions that varicella-zoster immune globulin was effective in pregnant patients as it neutralizes free virus. According to a literature review conducted by the authors, the infectionn of the disease declined to 1.1% in babies whose mothers had received varicella-zoster immune globulin compared to the 12.4% decrease in cases whose mothers did not receive the treatment. INSET: KEY POINTS.


Related Articles

  • Chickenpox in the immunocompromised child. Roderick, Marion; Finn, Adam; Ramanan, A. V. // Archives of Disease in Childhood;Jul2012, Vol. 97 Issue 7, p587 

    The article focuses on the state of chickenpox prevention in the immunocompromised children. It says that varicella zoster immunoglobulin (VZIG) has a significant threat for chickenpox in children who need immunosuppression, wherein VZIG has been shown to modify varicella infection. It also...

  • Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence. Cheong Soo Park; Dong Soo Kim; Ki Hwan Kim // Clinical & Experimental Vaccine Research;Jul2013, Vol. 2 Issue 2, p140 

    Purpose: There are different principles regarding varicella vaccination depending on social requirements. This study was performed to report a case of breakthrough chickenpox outbreak among a group of people in the healthcare center and also evaluate the seroprevalence of patients who have been...

  • Chickenpox at Ninety Four: A Case for Extending the Use of Varicella Vaccine in the UK. Bendig, Justin; Sindall, Fiona // Case Reports in Medicine;2010, p1 

    A case of chickenpox in a 94-year-old female is described. Serological tests for Varicella zoster virus (VZV) performed on early and late serum samples confirmed primary VZV infection. The patient recovered but seventeen days after presentation she developed a stroke from which she subsequently...

  • SuçiçeÄŸi Aşısı. Çokuğraş, Haluk // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Sep2008 Supplement, Vol. 2, p120 

    Whereas chickenpox is a mild disease in otherwise healthy children, varicella virus in an immundeficient individual may lead to a more serious form Varicella vaccine is licensed for use in healthy children at 12 months of age. In all countries except the USA, one dose of vaccine is recommended...

  • Prevention of Varicella. Marin, Mona; Güris, Dalya; Chaves, Sandra S.; Schmid, Scott; Seward, Jane F. // MMWR: Morbidity & Mortality Weekly Report;6/22/2007, Vol. 56 Issue RR-4, p1 

    Two live, attenuated varicella zoster virus-containing vaccines are available in the United States for prevention of varicella: 1) a single-antigen varicella vaccine (VARIVAX,® Merck & Co., Inc., Whitehouse Station, New Jersey), which was licensed in the United States in 1995 for use among...

  • Herpes zoster eruption associated with vaccine-strain varicella-zoster virus: A case report. Cimolai, Nevio; Krajden, Mel; Petric, Martin // British Columbia Medical Journal;Apr2014, Vol. 56 Issue 3, p135 

    Recipients of varicella-zoster virus vaccine for the prevention of chickenpox can suffer rare complications, including the development of vaccine-related zoster (shingles). Overall, the vaccine is effective in preventing chickenpox, but the medical community should be aware that vaccination can...

  • ACIP issues recommendations on the prevention of varicella.  // American Family Physician;12/1/1996, Vol. 54 Issue 8, p2578 

    Presents the summary of the Advisory Committee on Immunization Practices (ACIP) recommendations concerning the use of varicella virus vaccine on the prevention of varicella. Adverse events of varicella virus vaccine.

  • THE EFFECTIVENESS OF THE VARICELLA VACCINE IN CLINICAL PRACTICE. Shapiro, Eugene D. // Pediatric Dentistry;May/Jun2001, Vol. 23 Issue 3, p259 

    An abstract of the article "The Effectiveness of the Varicella Vaccine in Clinical Practice," by Eugene D. Shapiro is presented.

  • Varicella vaccine guidelines updated by NACI in Canada.  // PharmacoEconomics & Outcomes News;11/27/2010, Issue 617, p15 

    The article offers information on updates made by the National Advisory Committee of Immunisation (NACI) to its varicella vaccination guidelines in Canada.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics